Ratings changes post acquisition
Sibanye Gold (SBGL) entered into an agreement with Stillwater Mining (SWC) to acquire all its stock in December 2016. While Sibanye’s management is quite positive about this development, we’ll see how analysts are viewing this transaction.
Commenting on the Sibanye Gold–Stillwater Mining (SWC) deal, UBS said, “By Sibanye’s own admission, the valuation paid for Stillwater’s operating assets looks full.” UBS added that the market might not be factoring in the upside from the Blitz project.
J.P. Morgan Cazenove described this offer as “a very full price.” It also said that Sibanye would need to repay a debt of $865.0 million to return the company to a comfortable net debt-to-EBITDA (earnings before interest, tax, depreciation, and amortization) ratio of 1.5x.
AngloGold’s ratings changes
AngloGold Ashanti (AU) reported on February 2, 2017, that it expects to report a profit in 2016 after losing money in 2015. As far as recent analyst sentiment is concerned, HSBC downgraded AU from “buy” to “hold” while simultaneously reducing its target price from 208 South African rand to 165 South African rand on January 27, 2017.
On the other hand, it’s among RBC Capital Markets’ favorite picks. It falls within its purview of companies with “attractive margins, solid balance sheets, organic growth opportunities and a consistent operating strategy.”
Harmony Gold and Gold Fields
On February 3, 2017, HSBC raised Harmony Gold’s (HMY) target price from 34 South African rand to 35 South African rand.
HSBC lowered Gold Fields’ (GFI) target price from 61 South African rand to 43 South African rand and downgraded it from “hold” to “reduce” on January 27, 2017.
RBC Capital Markets downgraded GFI from “outperform” to “sector perform” on December 12, 2016.
According to Morgan Stanley Private Wealth Management's Andy Chase, long-term fundamentals look strong with the recent pickup in economic activity.
Hibbett Sports (HIBB) stock surged 22.3% as of 1:54 PM ET today as the company reported impressive results for fiscal 2019's fourth quarter, which ended on February 2.
Wall Street analysts expect a potential upside of 21.63% for Alexion Pharmaceuticals based on the stock's closing price on March 21.
Today, we got another round of dismal data points from Europe (VGK)(EZU). According to a Markit survey, Germany’s (EWG) March PMI Composite Output Index fell to a 69-month low of 51.5.
On March 21, US crude oil’s implied volatility was 24.9%, which was 6.7% below its 15-day average. Usually, lower implied volatility supports oil prices.
The overall cannabis sector took a hit today amid the broader market's declines. The volatility index (VIX) jumped 17.9%, and the cannabis sector is more sensitive than the market.
The tech-heavy NASDAQ Composite Index (QQQ) is on track to post its 12th weekly gain in 13 weeks.